News
-
-
-
-
-
-
-
-
PRESS RELEASE
Theralase(R) to Host Advisory Board Meetings at Canadian Urological Association Bladder Cancer Forum and the American Urological Association
Theralase Technologies Inc. to present latest Study II interim clinical data on Ruvidar™-based photodynamic therapy for BCG-Unresponsive NMIBC CIS at upcoming Advisory Board meetings in Toronto and San Antonio -
-
PRESS RELEASE
Dr. Michael Jewett Joins Theralase(R) to Help Complete Enrollment in the Phase II Non-Muscle Invasive Bladder Cancer Clinical Study
Theralase® Technologies Inc. announces the addition of Dr. Michael Jewett as an independent consultant to assist in completing enrollment of patients in the Phase II NMIBC CIS clinical study. Dr. Jewett's expertise will help achieve regulatory approval
-
Buildout, Inc. Unveils Game-Changing Technology Stack including an AI-Enabled Mobile App
-
Heal and Find Hope After a Friendship Breakup in When Best Friends Aren't Forever by Kristen Reed, Out Now
-
Viking Capital Announces Closing of Latest 268 Acquisition in Atlanta
-
Aflac: 6 Common Myths About Supplemental Insurance
-
Gabriel Resources Ltd. Initial Closing of Private Placement
-
Original-Research: Noctiluca S.A. (von East Value Research GmbH ):
-
Eurobattery Minerals increases its stake in the Finnish Hautalampi project to 100 per cent
-
Cairn Homes Plc: Transaction in Own Shares
-
Dalata Hotel Group PLC: HOL-Holding(s) in Company*
-
Sartorius Stedim Biotech Capital Markets: Links to presentation and webcast
-
VOGO : French National Handball League chooses VOGO to referee the French men’s championship (“Liqui Moly Starligue”).
-
ENGIE Q1 2024 Financial Information
-
Covivio Hotels successfully priced a €500 million 9-year Green Bond
-
Covivio Hotels successfully priced a €500 million 9-year Green Bond
-
AXA: Information relating to the number of voting rights and shares making up the share capital on 30/04/2024